Royal Bank of Canada
BIOSU

Royal Bank of Canada’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Royal Bank of Canada’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,000
Closed -$110K – 7928
2022
Q1 		$110K Buy
11,000
+1,000
+10% +$9.99K ﹤0.01% 5587
2021
Q4 		$100K Buy
+10,000
New +$100K ﹤0.01% 5944

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.97% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.5% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Royal Bank of Canada's BIOSU Position: Q2 2022 in Review

Royal Bank of Canada sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2022, closing a stake of 11,000 shares — an estimated $110K sold.

Royal Bank of Canada first reported a position in BIOSU in Q4 2021 and held it in 2 quarters. The position peaked at $110K in Q1 2022. 24 funds tracked by Wall St. Rank hold BIOSU as of Q2 2022.

  • Royal Bank of Canada reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 11,000 BioPlus Acquisition Corp. Unit shares in Q2 2022, an estimated $110K.
  • Royal Bank of Canada first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Royal Bank of Canada's BioPlus Acquisition Corp. Unit position peaked at $110K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.